Trump drops Biden’s Medicare obesity drug coverage proposal
Extending coverage for the medications through Medicare could cost $35 billion over nine years, a congressional analysis found.
Related Articles
HHS overhaul has PACE providers on edge
PACE providers are watching to see how a reorganization of the Medicare-Medicaid program could affect plans to build new PACE centers and enroll patients.
Emergency departments risk closing over pay, overcrowding: Rand
Here are five problems plaguing emergency departments, according to a new report from Rand.
GuideWell’s CEO weighs in on prior authorization, ACA subsidies
The Florida Blue parent company uses artificial intelligence to review 80% of prior authorization requests.
One-on-One with Robin Roberts of PointClickCare
Robin Roberts, Director of Health IT Regulatory Affairs at PointClickCare, offers expert guidance to successfully navigate TEAM including how to optimize post-acute care relationships and…
This Fiber Supplement Can Help With Weight Loss—And Now, Brain Health. Should You Take It Every Day?
A nutrient that really can do it all.
Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial
Nature Communications – Here, the authors present the results of the PROMOTe trial, reporting improved cognition with prebiotic vs placebo in twins over 60 years…
Association of Dietary Inflammatory Potential with Inflammatory Biomarkers in Brazilian Children: The Role of Obesity Status in the South American Youth/Child Cardiovascular and Environmental (SAYCARE) Study | Childhood Obesity
Background: The objective of this study was to test the association of Pro-Inflammatory/Anti-Inflammatory Food Intake Score (PAIFIS) and inflammatory biomarkers: C-reactive protein (CRP), tumor necrosis…
Personality, eating behaviour, and body weight: results from the population study of women in Gothenburg 2016/17
International Journal of Obesity – Personality, eating behaviour, and body weight: results from the population study of women in Gothenburg 2016/17
Association of tirzepatide with glycaemic control and weight loss in a real world cohort of patients with type 2 diabetes from the United States
Aims The goal of this observational, single-cohort, pre-post study was to describe the association of tirzepatide with glycaemic control and weight loss in patients with…
Obesity-drug pioneers and 13,508 physicists win US$3-million Breakthrough Prizes
Nature – Advances recognized by science’s most lucrative awards include Large Hadron Collider experiments and groundbreaking weight-loss treatments.